Diabetic Care

DECAGLIM-M1

Glimepiride 1 mg + Metformin Hydrochloride ER 500 mg

Tablets 3D representation
Medicine Type:Tablet Type360°
Diabetic Care
Tablets

DECAGLIM-M1

DECAGON PHARMACEUTICALS

Dosage Form
Tablets
Packaging
10 x 10 Tablets / Blister Pack
Contact Medical Representative
Product Introduction

Overview of DECAGLIM-M1

DECAGLIM-M1 Tablets combine Glimepiride (1 mg) and Metformin Hydrochloride Extended Release (500 mg). Scientifically formulated to manage proper glucose levels for well-being by stimulating physiological insulin release and reducing hepatic glucose output.

Designed For / Target Audience

Indicated for patients with Type 2 Diabetes inadequately controlled on monotherapy (sulfonylurea or metformin alone), hyperinsulinemia, and for the prevention of diabetic macrovascular and microvascular complications.

Suitable Scientific Claim for Promotional Literature

"DECAGLIM-M1 — Manage Proper Glucose Level for Well-Being."

Clinical Evidence Context: Indications: Type 2 Diabetes Mellitus, Hyperinsulinemia, and Prevention of Macrovascular & Microvascular Complications.

Therapeutic Category

Diabetic Care

Dosage Form & Delivery

Tablets

Disclaimer: DECAGLIM-M1 is a prescription antidiabetic medicine. Use under the guidance of a qualified healthcare professional.